Back

Myeloperoxidase predicts 12-month heart failure risk after ST-elevation myocardial infarction treated with percutaneous coronary intervention (PCI)

10 May 2026 (11:30 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in coronary artery disease (chronic) / chronic coronary syndromes (2) Revascularisation Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Alla Kobets

L.T.Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine, Kharkiv (Ukraine)

5 More presentations in this session

Presentation thumbnail
Clinical profile and 1-year mortality predictors in left main coronary artery percutaneous coronary intervention for acute myocardial infarction
Doctor T. Carlos (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Heart failure phenotype and postoperative outcomes following coronary artery bypass grafting
Doctor A. Djordjic (Belgrade, RS)
Abstract Slides
Presentation thumbnail
Relationship between PET-CT ischemia reduction and echocardiographic recovery after CTO-PCI
Doctor T. Carlos (Coimbra, PT)
Abstract Slides
Presentation thumbnail
Medical therapy in spontaneous coronary artery dissection: the role of beta-blockers and statins
Miss J. Conde Goncalves (Porto, PT)
Abstract Slides
Presentation thumbnail
Clinical risk stratification in spontaneous coronary artery dissection: development and incremental validation of a prognostic model
Doctor L. Lorenzo Alves (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in coronary artery disease (chronic) / chronic coronary syndromes (2)

The Event

Event poster

Heart Failure 2026

10 May 2026 11:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources